CN Patent

CN115260108B — 一种酸的共晶及其制备方法

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2025-10-21 · 1y expired

What this patent protects

本发明主要提供了一种酸的共晶及其制备方法，属于医药技术领域。本发明提供的共晶具有较好的稳定性和溶解性能，可应用于药物制剂。

USPTO Abstract

本发明主要提供了一种酸的共晶及其制备方法，属于医药技术领域。本发明提供的共晶具有较好的稳定性和溶解性能，可应用于药物制剂。

Drugs covered by this patent

Jesduvroq (DAPRODUSTAT) · GSK

Patent Metadata

Patent number: CN115260108B
Jurisdiction: CN
Classification: —
Expires: 2025-10-21
Drug substance claim: No
Drug product claim: No
Assignee: Sunshine Lake Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.